Kaleido Stock Future Price Prediction

KLDO -  USA Stock  

USD 5.35  0.03  0.56%

Kaleido Biosciences stock price prediction is an act of determining the future value of Kaleido Biosciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Kaleido Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kaleido Biosciences and does not consider all of the tangible or intangible factors available from Kaleido Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Kaleido Biosciences, which may create opportunities for some arbitrage if properly timed.
Please see Kaleido Biosciences Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kaleido Biosciences based on different types of headlines from major news networks to social media. The Kaleido stock price prediction module provides an analysis of price elasticity to changes in media outlook on Kaleido Biosciences over a specific investment horizon. Using Kaleido Biosciences hype-based prediction, you can estimate the value of Kaleido Biosciences from the perspective of Kaleido Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
Kaleido Biosciences Book Value per Share is quite stable at the moment as compared to the past year. The company's current value of Book Value per Share is estimated at 0.66. Current Ratio is expected to rise to 4.08 this year, although the value of Earnings per Basic Share will most likely fall to (2.63) .
This module is based on analyzing investor sentiment around taking a position in Kaleido Biosciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kaleido Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Kaleido because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Kaleido Biosciences after-hype prediction price

    
  $ 5.54  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kaleido Biosciences in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
4.347.4410.54
Details
5 Analysts
Consensus
LowTarget PriceHigh
5.0014.6022.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-2.63-2.31-2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kaleido Biosciences. Your research has to be compared to or analyzed against Kaleido Biosciences' peers to derive any actionable benefits. When done correctly, Kaleido Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kaleido Biosciences.

Kaleido Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Kaleido Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kaleido Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Kaleido Biosciences, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Kaleido Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Kaleido Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kaleido Biosciences' historical news coverage. Kaleido Biosciences' after-hype downside and upside margins for the prediction period are 2.44 and 8.64, respectively. We have considered Kaleido Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
5.35
16th of September 2021
5.54
After-hype Price
8.64
Upside
Kaleido Biosciences is somewhat reliable asset. Analysis and calculation of next after-hype price of Kaleido Biosciences is based on 499' months time horizon.

Kaleido Biosciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Kaleido Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kaleido Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kaleido Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.48  3.10  0.16   0.69  3 Events / Month1 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
5.355.542.97 
911.76  

Kaleido Biosciences Hype Timeline

Kaleido Biosciences is now traded for 5.35. The entity has historical hype elasticity of 0.16 and average elasticity to hype of competition of -0.69. Kaleido is forecasted to increase in value after the next headline with price projected to jump to 5.54 or above. The average volatility of media hype impact on the company stock price is over 100%. The price upswing on the next news is forecasted to be 2.97% whereas the daily expected return is now at -0.48%. The volatility of related hype on Kaleido Biosciences is about 216.78% with expected price after next announcement by competition of 4.66. The company currently holds 21.19 M in liabilities with Debt to Equity (D/E) ratio of 0.3, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 3 days.
Please see Kaleido Biosciences Basic Forecasting Models to cross-verify your projections.

Kaleido Biosciences Related Hype Analysis

Having access to credible news sources related to Kaleido Biosciences' direct competition is more important than ever and may enhance your ability to predict Kaleido Biosciences' future price movements. Getting to know how Kaleido Biosciences rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kaleido Biosciences may potentially react to the hype associated with one of its peers.

Kaleido Biosciences Additional Predictive Modules

Most predictive techniques to examine Kaleido price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kaleido using various technical indicators. When you analyze Kaleido charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kaleido Biosciences Predictive Indicators

The successful prediction of Kaleido Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kaleido Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kaleido Biosciences based on analysis of Kaleido Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kaleido Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kaleido Biosciences's related companies.

Story Coverage note for Kaleido Biosciences

The number of cover stories for Kaleido Biosciences depends on current market conditions and Kaleido Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kaleido Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kaleido Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Kaleido Biosciences Short Properties

Kaleido Biosciences' future price predictability will typically decrease when Kaleido Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kaleido Biosciences often depends not only on the future outlook of the potential Kaleido Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaleido Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out7.94%
Short Percent Of Float16.12%
Float Shares20.94M
Shares Short Prior Month3.25M
Average Daily Volume Last 10 Day103.48k
Average Daily Volume In Three Month252.87k
Date Short Interest28th of May 2021
Please see Kaleido Biosciences Basic Forecasting Models to cross-verify your projections. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.